Cardiac drug safety is a major concern and one of the sticking points throughout cardiac drug development. Therefore, improving in vitro assays at the early phases of drug development is critical in preventing late-stage failure.
In vitro cell cultures are a powerful models for the accurate analysis of human heart disorders and therefore suitable to perform cardiotoxicity assays. Many of these disorders are the result of subtle changes to cardiomyocyte excitability, contractility, or both. Our products aim to provide our customers with powerful tool for accurately measuring changes in depolarization, repolarization, and, indeed, detecting drug-related adverse responses.
Our products cover two main application areas: